SWI Editorial Staff2025-12-24T00:59:45-08:00Sanofi receives FDA complete response letter for MS drug tolebrutinib By Investing.comSWI Editorial Staff2025-12-24T00:59:45-08:00December 24, 2025|
SWI Editorial Staff2025-12-24T00:59:16-08:00Sanofi to acquire Dynavax for $2.2 billion in cash deal By Investing.comSWI Editorial Staff2025-12-24T00:59:16-08:00December 24, 2025|
SWI Editorial Staff2025-12-24T00:58:42-08:00Stonepeak to acquire majority stake in Castrol for $10.1 billion By Investing.comSWI Editorial Staff2025-12-24T00:58:42-08:00December 24, 2025|
SWI Editorial Staff2025-12-24T00:58:05-08:00Can Philips extend margin gains after FY25? Jefferies stays cautious By Investing.comSWI Editorial Staff2025-12-24T00:58:05-08:00December 24, 2025|
SWI Editorial Staff2025-12-24T00:55:26-08:00Why an analyst sees Meta shares getting back to record highs – plus, another tariff reprieSWI Editorial Staff2025-12-24T00:55:26-08:00December 24, 2025|
SWI Editorial Staff2025-12-24T00:54:53-08:00Meta Platforms (META) Monness Crespi Hardt Cuts Target Forecast on Valuation AdjustmentSWI Editorial Staff2025-12-24T00:54:53-08:00December 24, 2025|